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INTRODUCTION: Prevention of tooth loss and maintaining favorable periodontal status are 
the ultimate goals of periodontal therapy. The aim of this study was to evaluate the effectiveness 
of non-surgical periodontal therapy and supportive periodontal care in arresting the progression 
of chronic periodontitis and in preventing tooth loss. 
 
MATERIALS AND METHODS: Periodontal charts, self-reported medical history, and 
interleukin-1 (IL-1) polymorphism genotypes of 100 patients were obtained from the University 
of Pittsburgh School of Dental Medicine Dental Registry and DNA Repository (DRDR) after 
screening of 4,825 subjects. In our study we have included third molars, teeth lost during active 
periodontal treatment (APT), and those lost during supportive periodontal care (SPC). We used 
tooth loss (TL) and clinical attachment loss (CAL) as outcomes of disease affection in our 
analysis. Fisher’s exact test was used to investigate the association between tooth loss and 
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different risk factors. Paired t-test was conducted to detect the difference in means of CAL 
between baseline and final periodontal assessments. 
 
RESULTS: There were 59 patients (36 males and 23 females with an average age of 52 years) 
that lost at least one tooth. Tooth mortality rate declined in patients who attended supportive 
periodontal program for six years compared to those who received supportive periodontal 
therapy for one year only (0.52 and 3.4 teeth/patient/year, respectively). Increased risk of tooth 
loss was found to be associated with diabetes (P=0.01), as well as high blood pressure 
(P<0.0001). We did not find an association between tooth loss and polymorphisms in interleukin 
IL-1α/IL-1β  (rs1800587, P=0.36 and rs1143634, P=0.51, respectively). During the first year of 
supportive periodontal treatment, the clinical attachment loss showed a significant reduction 
(CAL gain of 0.36 mm, P=0.0697). Moreover, a significant increase in CAL was noted in the 
group of patients who attended regular periodontal maintenance for six years (CAL progression 
of 0.38mm, P=0.037). 
 
CONCLUSION: Our findings suggested that supportive periodontal therapy is effective for the 
long-term stability of periodontal disease in high-risk patients in our sample. 
 
KEYWORDS: Supportive periodontal therapy, Tooth loss, Chronic periodontitis. 
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1.0  INTRODUCTION 
1.1 PERIODONTAL DISEASE 
Periodontal disease (periodontitis) can be defined as an inflammatory disease that affects the 
teeth-supporting tissues in response to microbial pathogens and can lead to tooth loss if left 
untreated (Williams, 1990). Bacterial biofilm is the primary etiological factor for the initiation of 
gingivitis and the subsequent periodontal tissues destruction (Haffajee and Socransky, 1994). 
The complex interaction between periodontal pathogens and the protective host response 
determines the outcome of the disease (Page et al., 1997). 
 
 The clinical diagnosis of periodontitis is based on the presence of gingival inflammation, 
periodontal pockets, loss of clinical attachment and alveolar bone loss (Page and Eke, 2007). 
Clinical attachment loss (CAL) is considered to be the gold standard in the diagnosis and in the 
measurement of past periodontal disease activity (American Academy of Periodontology, 2003). 
Measuring the Clinical attachment loss is found to be more accurate in evaluating the periodontal 
disease progression compared to periodontal pocket depth (Page and Eke, 2007).  
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              Attachment loss and destructive periodontitis are found to be more prevalent in males 
than females and are more prevalent in Blacks and Mexican Americans than Whites. In the 
United States, the prevalence of attachment loss   ≥ 3 mm reached 53.1% among adults who aged 
≥ 30 years with an average of 19.6% affected teeth per person. It was estimated that at least 35% 
of the adult U.S population have periodontitis with 21.8% having a mild form and 12.6% having 
a moderate or severe form of periodontitis (Albandar et al., 1999). The most updated report on 
the prevalence of periodontitis in the United States revealed that 46% of US adults who were 
aged ≥30 years had periodontitis with 8.9% of them diagnosed with severe periodontitis (Eke et 
al., 2015). 
 
 
1.2 SUSCEPTIBILITY TO PERIODONTAL DISEASE PROGRESSION 
Periodontitis is a complex multifactorial disease that involves the interaction of environmental 
factors such as smoking and the patient’s related factors such as: sex, age and systemic diseases. 
Over the years, researchers have focused on the effect of the aforementioned factors in the onset 
and the progression of periodontal disease as well as the healing process. It is widely accepted 
that individuals vary greatly in the susceptibility of periodontal disease, the clinical 
manifestations, the rate of disease progression, and the therapeutic responsiveness (Socransky 
and Haffajee, 1992). 
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1.2.1 Diabetes 
Diabetes mellitus is a group of metabolic diseases that are characterized by hyperglycemia 
resulting from disturbances in either insulin production or function, or both (American Diabetes 
Association, 2009). Periodontitis has been identified as the sixth complication of diabetes, and 
the rate of periodontal disease among diabetic patients was found to be three times greater than 
that in non-diabetics. Furthermore, diabetic patients with retinopathy are five times more likely 
to have advanced periodontal disease than those without retinopathy (Löe, 1993). It has been 
hypothesized that inflammatory periodontal diseases may increase insulin resistance that can 
aggravate glycemic control in a way similar to obesity (Mealey and Oates, 2006).  
 
 Further research is needed to clarify the nature of this two-way relationship between 
periodontal diseases and diabetes and to validate the impact of periodontal treatment on glycemic 
control of diabetes taking into consideration the type of diabetes mellitus, the severity of 
periodontal disease, and the types of periodontal therapy (Lalla and Papapanou, 2011).  
 
In a national sample study by Kapp et al., a stronger association between tooth loss and 
diabetes was detected among younger age groups. Furthermore, diabetic patients were 1.46 times 
as likely to have at least one tooth removed than non-diabetics (Kapp et al., 2007). 
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1.2.2 Hypertension 
Hypertension is a major global health issue that is considered to be the leading cause of death in 
individuals with cardiovascular diseases. It was estimated that by the year 2025, there would be 
1.56 billion cases of hypertension (Kearney et al., 2005).  
           It was reported that there is an inverse association between the number of teeth and the 
increased in systolic blood pressure in men (Völzke et al., 2006). Also, a significant association 
was found between tooth loss and an increased risk of hypertension in postmenopausal women 
(Taguchi et al., 2004). The possible association between tooth loss and increased risk of ischemic 
heart disease in men can be due to the common risk factors for both diseases (Paunio, et al., 
1993).  
            For a better understanding of the causal relationship between tooth loss or periodontal 
disease and hypertension, large longitudinal studies that include all the possible confounding 
variables are needed. 
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1.2.3 Smoking 
Smoking has been established as a true risk factor for periodontitis. It was found that smokers 
displayed less favorable healing responses compared with non-smokers (Ah et al., 1994). 
Moreover, there is a smoking-induced suppressive effect on the hemorrhagic responsiveness 
among smokers with periodontitis (Preber and Bergström, 1985; Bergström and Boström, 2001). 
The relationship of smoking exposure and periodontal disease was found to be dose-dependent 
and heavy exposure was consistently associated with the severity of periodontal disease 
(Bergström et al., 2000). Limited information is available on the effects of smoking cessation on 
the clinical outcomes of periodontal treatment. A recent meta-analysis concluded that there is a 
positive impact of smoking cessation on periodontal tissue in terms of probing depth reduction 
and clinical attachment gain (Chambrone et al., 2013). 
 
1.2.4 Interleukin-1 Genotype (IL-1) 
In 1997, Kornman introduced the possible association between composite interleukin-1 (IL-1) 
genotype and periodontal disease. Since then, a tremendous progress has been made in 
understanding the genetic basis for periodontal diseases. Interleukin-1 (IL-1) is a potent pro-
inflammatory cytokine that has two structurally distinct forms, IL-1α and IL-1 β, which are 
encoded by separate genes that are located on the long arm of chromosome 2 (2q14-21). IL-1 
secreted as a cluster that also includes IL-1 receptor antagonist gene that regulates the function of 
IL-1 (Dinarello, 1996; Kornman et al., 1997). 
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 The interaction between environmental and genetic factors to clinical measures of 
periodontal disease was examined in 110 pairs of adult twins (mean age 40.3 years). The 
studying population consisted of 63 monozygous and 33 dizygous twin pairs reared together and 
14 monozygous twin pairs reared apart. Heritability estimates between 38% to 82% of the 
population variance, indicated that periodontal measures including gingivitis, probing depth, 
attachment loss and plaque may be attributed to genetic factors. Furthermore, a greater variation 
was detected between monozygotic twins than between dizygotic twins (Michalowicz et al., 
1991; Seymour, 1991; Michalowicz, 1994; Michalowicz et al., 2000). Contradictory results have 
been reported regarding the associations between interleukin-1 polymorphisms and the 
periodontal disease progression, as well as treatment outcomes (McDevitt et al., 2000; 
Papapanou et al., 2001; Rogers et al., 2002; Sakellari et al., 2003).  
 
From the data currently available, it seems fair to suggest that the IL-1 genotype can be 
tested to predict the success of periodontal therapy. However, based on a recent re-analysis of 
published data by Diehl, et al., there is no evidence to support the benefits of genetic testing for 
IL-1 polymorphisms, such as IL-1 periodontal sensitivity testing (PST) or PerioPredict, in high-
risk patients (Diehl et al., 2015). 
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1.3 TREATMENT OF CHRONIC PERIODONTITIS 
The primary goal of periodontal therapy is to arrest the progression of periodontal destruction. 
Treatment of periodontal disease depends mainly on the type and the severity of periodontal 
disease in addition to other patients’ related factors. Periodontal therapy involves mechanical 
removal of the sub-gingival biofilm and debridement of the mineralized deposits on the root 
surface to re-establish a biocompatible environment with healthy periodontal tissues.  
1.3.1  Non-Surgical Periodontal Therapy 
The effectiveness of non-surgical periodontal therapy regarding clinical parameters such as 
changes in clinical attachment level, probing pocket depth, and bleeding on probing for patients 
with chronic periodontitis has been discussed in many studies (Badersten et al., 1984; Lindhe et 
al., 1984; Cobb, 2002).  
 
           At the beginning of the 1990s, non-surgical periodontal therapy was performed using 
power driven scalers instead of hand instruments. Several studies failed to detect a significant 
difference between these two methods with regards to clinical parameters such as; Clinical 
attachment level gain, reduction in periodontal probing depth, tooth loss and bleeding on probing 
(Tunkel et al., 2002; Walmsley et al., 2008; Ioannou et al., 2009). On the other hand, ultrasonic 
debridement was found to take significantly less time than mechanical debridement using hand 
instruments (Tunkel et al., 2002; Walmsley et al., 2008).  
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            There is no sufficient evidence of the long-term superior effectiveness of the Erbium-
doped yttrium aluminum garnet (Er:YAG) laser compared to scaling and root planning in 
treating chronic periodontitis (Sculean et al., 2004; Schwarz et al., 2008; Sgolastra et al., 2012).  
 
            Chronic periodontal disease can be successfully treated, even in advanced stages by non-
surgical or surgical periodontal therapy with adequate plaque control that can be maintained 
during supportive periodontal therapy (Lindhe and Nyman, 1975; Axelsson and Lindhe, 1981). 
 
1.3.2 Supportive Periodontal Therapy (SPT) 
The link between oral and systemic health is receiving significant interest in the dental field; 
thereby many researchers have attempted to identify how these risk factors can influence the 
progression of periodontal attachment loss as well as tooth loss. Tooth loss due to periodontal 
disease is associated with several risk indicators including; age, being of the male sex, smoking, 
diabetes mellitus, hypertension, rheumatoid arthritis, lack of professional maintenance, and 
anterior tooth type (Al-Shammari et al., 2005). The patients’ risk assessment should be 
performed after the completion of initial cause-related therapy (ICRT) and revisited continuously 
(Renvert and Persson, 2004).  
 
A twelve years longitudinal study revealed that supportive periodontal therapy can 
prevent tooth loss and maintain the stability of bone and attachment loss among subjects with 
normal susceptibility to periodontal disease (with mean overall attachment loss of 0.5 mm, i.e. 
0.04 mm/tooth surface/year). However, highly susceptible patients who received a similar 
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supportive treatment experienced significant bone and attachment loss (CAL loss of 0.8 mm, i.e., 
0.06 mm/tooth surface/year) (Rosling et al., 2001).  
 
 It was reported that patients treated for advanced periodontitis continued to loose teeth 
despite maintenance care, and tooth loss was significantly more prevalent among smokers 
(Ravald and Johansson, 2012). Poorly compliant patients should be considered to be at a higher 
risk of periodontal disease progression and tooth loss.  A recent study has investigated the impact 
of irregular compliance to periodontal maintenance on tooth loss. It was found that individuals 
with irregular compliance exhibited a significantly higher rate of tooth loss  (0.36 tooth lost/year) 
compared with regular compliance individuals (0.12 tooth lost/year). Individuals that were > 55 
years old, males, and smokers lost significantly more teeth under the supportive periodontal 
therapy for five years (Costa et al., 2014).  Patient compliance to supportive periodontal therapy 
is considered an important factor in the success of the periodontal treatment and prevention of 
tooth loss. One study reported that a mean of tooth loss of 0.07 tooth/year was observed among 
compliant patients for ten years of supportive periodontal therapy (König et al., 2002). 
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1.4 SPECIFIC AIMS AND OBJECTIVES 
 
1. To assess the frequency and the severity of clinical attachment loss of periodontal tissue 
in a sample with at least one year longitudinal follow-ups. 
2. To evaluate the association between tooth loss and patient-related risk factors for 
periodontal disease.  
3. To evaluate the aggregate tooth loss in a sample of periodontal treated patients with at 
least one year longitudinal follow-ups. 
4. To evaluate the changes in clinical attachment loss in a sample of periodontal treated 
patients with at least one year longitudinal follow-ups. 
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2.0  SUBJECTS AND METHODS 
2.1 STUDY SETTING 
Dental Registry and DNA Repository (DRDR) is a database that was established in 2006. Every 
patient that has been treated at the University of Pittsburgh School of Dental Medicine receives 
an invitation to participate in the registry and signs a consent form authorizing the retrieval of 
information from their dental records. The study is approved by University of Pittsburgh 
Institutional Review Board (IRB approval#0606091). 
2.2 STUDY PARTICIPANTS 
The subjects were recruited from (DRDR) and they were selected based on the following criteria:  
1. Patients that have been diagnosed with moderate to severe chronic periodontitis. 
2. The participant should have received at least three periodontal assessments (baseline, re-
evaluation and final evaluation). 
3. The patient must have been attended regular supportive periodontal therapy for a 
minimum of 12 months. 
4. The participant should have completed information on medical history and IL-1 
genotype. 
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Upon the screening of 4,825 dental records, 100 subjects met our selection criteria. In order to 
assess the long-term effectiveness of non-surgical periodontal therapy, both tooth loss and 
clinical attachment loss were used as an outcome of periodontal disease.  
 
Tooth loss was counted when subjects lost one or more teeth after periodontal therapy and were 
compared to subjects who did not have any tooth loss. In order to measure the changes in clinical 
attachment loss (CAL), the patients were grouped based on the follow-up period that elapsed 
from the baseline to the final periodontal assessments they had. The follow-up period ranged 
from one to six years and the sample size experienced gradual attrition until it reached 17 
subjects when the 6-year follow-up period was over. 
 
 Of all of the 100 enrolled patients, 69 were Caucasians, 29 were African-Americans, and one 
patient was of Asian origin, and another of Hispanic origin. There were 46 females and 54 males 
in the total sample. At the time of the initial examination, the average age was 53.07 years old 
and ranged from 20 to 91 years old (Table 1). 
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Table 1. Demographic characteristics of the study subjects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables N=100 
Women  46 
Men  54 
Asian  1 
African-American  29 
Caucasian  69 
Hispanic  1 
Smoker  22 
Non-smoker  64 
Former smoker  14 
Diabetes  12 
Hypertension  39 
Hepatitis  4 
Sickle cell anemia  4 
Epilepsy  3 
Stroke  4 
Asthma  15 
Tuberculosis  4 
Cancer  13 
Healthy  23 
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2.3 CASE DEFINITION 
Severe periodontitis is defined as the presence of two or more interproximal sites with CAL ≥ 6 
mm, not on the same tooth, and one or more interproximal sites with Probing Depth (PD) ≥ 5 
mm. While, Moderate periodontitis is defined as the presence of two or more interproximal sites 
with CAL ≥ 4 mm, not on the same tooth, or two or more interproximal sites with PD ≥ 5 mm, 
not on the same tooth (Page and Eke, 2007).  
2.4 IL-1 GENOTYPES 
The genotypes data were provided from Vieira’s lab. Genomic DNA was extracted from saliva 
and the genotypes were generated using Taqman chemistry (Ranade et al., 2001). The reactions 
were carried out with the use of standard conditions as suggested by the manufacturer 
2.5 	PERIODNTAL ASSESMENTS 
Each subject had at least two periodontal assessments in addition to the baseline assessment, 
resulting in 456 periodontal assessments for the total sample size.  
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2.6 	STATISTICAL ANALYSIS 
 
All collected data were entered using Excel spreadsheets and the statistical analyses were 
performed using R programming language at 5% significance level and 95% confidence interval. 
Genetic Analyses were performed using PLINK Whole genome association analysis software 
version 1.9. 
 
Fisher’s exact test was used to determine the relationship between tooth loss and risk 
factors including: age, sex, ethnicity, self-reported medical and smoking history. 
 
Paired t-test was conducted to detect the difference between baseline and final CAL 
measurements (labial/buccal, palatal/lingual, and full mouth CAL) in patients stratified by 
follow-up periods, age and health status. 
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3.0   RESULTS 
3.1 TOOTH LOSS 
 In this study we have included third molars (periodontally functional), teeth that were extracted 
during active periodontal treatment (APT), and teeth lost during supportive periodontal care 
program (SPC).  
 
At the baseline evaluation, there were 2,482 present teeth and 718 missing teeth for all study 
subjects. The number of missing teeth increased to 906 missing teeth (2,294 present teeth) at the 
final evaluation. We have grouped the study participants in to two categories; those who 
maintained zero tooth loss (41 subjects, TL=0) and those who lost one or more teeth (59 
subjects, TL>0). During the follow–up period, 59 of the participants (36 male and 23 female, 
with an average age of 52 years) lost 188 teeth, which added 20.8% to the total number of 
missing teeth at the final periodontal evaluation.  
 
About 39.1% of the total missing teeth at the initial periodontal evaluation and 31% at the final 
periodontal evaluation came from the group of 41 subjects (18 male and 23 female, with an 
average age of 54 years of age) (Tables 2, 3 & 4). 
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The baseline periodontal evaluations showed that molars were the most frequently missing teeth, 
whereas canines were the least commonly missing teeth among all participants (Table 5 & 6). 
Throughout the (APT), 68 teeth were extracted with mean tooth loss of 0.68 teeth/patient. This 
number increased to 120 teeth during the (SPC) with mean tooth loss of 1.2 teeth/patient. Molars 
were lost at a higher frequency compared with incisors during (APT) as well as (SPC), (Table 7).  
 
Tooth mortality rate declined when comparing the group of patients who received supportive 
periodontal therapy for one year (3.4 tooth mortality rate/patients /year) with those who were at 6 
years supportive periodontal therapy (0.52 tooth mortality rate/patients /year), (Table 8). 
 
 
Table 2. Distribution of subjects by the number of teeth lost 
 
 
 
 
 
 
 
 
TL=0 TL=1 TL=2 TL=3 TL=4 TL=5 
41 25 9 5 7 2 
TL=6 TL=7 TL=13 TL=9 TL=10 Total pt with TL>0 
3 2 1 3 2 59 
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Table 3. Distribution of 188 teeth lost with regards to types of teeth in (TL>0 group) 
 
 
 
 
 
 
Table 4. Distribution of missing teeth during the follow-up period in (TL=0 group) 
 
 
 
 
 
 
 
 
Tooth# 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
#Missing teeth 6 5 8 7 7 5 5 6 2 5 0 12 14 7 11 3 
Tooth# 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
#Missing teeth 7 10 9 3 4 0 2 4 3 3 0 8 4 9 9 10 
Tooth# 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
#Missing teeth 30 13 9 8 7 3 3 4 3 3 3 9 7 3 9 34 
Tooth# 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
#Missing teeth 31 8 15 2 1 2 0 2 2 1 2 0 11 13 12 31 
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Table 5. Distribution of missing teeth at baseline and final periodontal evaluations 
 
 
 
Table 6. Distribution of missing teeth with regards to types of teeth at baseline and final 
periodontal assessments 
 
 
 
 
 
 
 
 
 
 
Tooth# 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Baseline  78 33 23 23 20 7 10 9 12 12 10 18 16 22 30 84 
Final 84 38 31 30 27 12 15 15 14 17 10 30 30 29 41 87 
Tooth# 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
Baseline 77 21 30 11 6 4 3 5 4 3 3 3 19 27 24 71 
Final 84 31 39 14 10 4 5 9 7 6 3 11 23 36 33 81 
Type of missing teeth Baseline Final 
Missing anterior 82 117 
Missing premolars 116 175 
Missing molars 520 614 
Total missing teeth 718 906 
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Table 7. Distribution of the type of teeth lost during APT and SPC 
 
 
 
 
Table 8. Tooth mortality rate per patient per year 
 
 
 
 
 
 
Missing teeth APT SPC 
Missing anterior 7 28 
Missing premolars 26 33 
Missing molars 35 59 
Total teeth loss 68 120 
Follow-up period Tooth mortality rate 
1-year 3.4 
2-years 1.14 
3-years 0.81 
4-years 0.89 
5-years 0.77 
6-years 0.52 
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3.2 TOOTH LOSS AND RISK FACTORS 
The relationships between each predictor variables and tooth loss were explored by using 
Fisher’s exact test. We found a statistically significant association between tooth loss and 
diabetes as well as tooth loss and hypertension (P=0.014 and P=6.7 26e-07, respectively). 
 
Table 9. Association between tooth loss and risk factors 
 
 
 
 
 
 
 
 
 
Variable TL=0 TL>0 Fisher’s exact test  
With Diabetes 9 3 0.014* 
Without Diabetes 32 56 
Healthy 9 14 1  
Systemic disease 32 45 
With Epilepsy 0 3 0.267 
Without Epilepsy 41 56 
With Stroke 2 2 1 
Without Stroke 39 57 
With Asthma 7 8 0.78 
Without Asthma 34 51 
With Tuberculosis 2 2 1 
Without Tuberculosis 39 57 
              With Sickle cell anemia 2 2 1 
Without Sickle cell anemia 39 57 
With Hepatitis 2 2 1 
Without Hepatitis 39 57 
With High blood pressure 18 2 6.7 26e-07* 
Without High blood pressure 23 57 
With Cancer 5 8 1 
Without Cancer 36 51 
Female 23 23 0.106 
Male 18 36 
African-American 14 15 0.137 
Other 2 0 
Caucasian 25 44 
Non-smoker 29 35 0.503 
Smoker 7 15 
Former smoker 5 9 
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3.3 TOOTH LOSS AND IL-1 GENOTYPES 
Genetic analyses were performed comparing subjects who lost one or more teeth with 
individuals who maintained zero tooth loss using PLINK Whole genome association analysis 
software version 1.9. The results of the association analysis in the study groups are presented in 
Table 10. No significant associations were observed between any of the IL-1 polymorphisms and 
tooth loss (rs1800587, P = 0.36 and rs1143634, P = 0.51). These findings were confirmed by 
running Fisher’s exact test under a dominant model to test the association between tooth loss and 
the genotypes containing the minor allele A in both SNPs (Table 11). 
Table 10. Genotype analysis of tooth loss 
 
 
Table 11. Genetic association of IL-1 genotypes and tooth loss 
 
Ch SNP BP A1 F_A F_U A2 Chi-sq P-value OR SE 95% CI MAF 
2 rs1800587 112785383 A 0.25 0.195 G 0.824 0.3641 1.38 0.352 (0.69-2.74) 0.227   
2 rs1143634 112832813 A 0.38 0.333 G 0.428 0.5132 1.22 0.307   (0.67-2.23) 0.361 
SNP/genotypes 
 
Test /model         TL>0 
 
TL=0 
 
Fisher’s exact test 
IL1-A (rs1800587) 
AA/AG/GG  Genotype          7/30/21 4/18/17 0.764 
AA + AG vs GG Dominant model            37/21 22/17 0.527 
AA vs AG + GG Recessive model             7/51 4/35 1 
IL1-B (rs1143634) 
AA/AG/GG  Genotype            4/21/33 
 
2/12/27 0.666 
AA + AG vs GG Dominant model             25/33 
 
14/27 0.409 
AA vs AG + GG Recessive model              4/54 2/39 1 
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3.4 TOOTH LOSS AND AGE 
Of all participants, 18% were aged between 20 - 39 years old (younger group) and 82% were 
aged 40- 91 years old (older group), (Table 12). The baseline age distribution with follow-up 
periods and the number of teeth lost is summarized in Table 13 and Figure 1.  
In our analysis the association between tooth loss and aging was found to be non-significant 
(Fisher’s exact test, P=0.43), (Table 14). When comparing situations between the two groups, the 
number of missing teeth at baseline as well as at final periodontal evaluation was found to be 
higher in older group (645 missing teeth in the older group compared with 73 in the younger 
group at baseline and 812 missing teeth in the older group compared with 94 in the younger 
group), (Table 15). The mean of tooth loss was significantly increased in both groups (younger 
group, P=0.006 and for older group P=0.0001) and molars were the most significantly lost teeth 
in both groups (younger group, P=0.011 and for older group P=0.0001). Older group showed 
significant difference in the mean of tooth loss with respect to all teeth types (Table 16). 
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Table 12. Demographic characteristics at baseline evaluation in both age groups 
 
 
 
 
 
Baseline evaluation Younger group (N=18) Older group (N=82) 
Women  9 (50%) 37 (45.1%) 
Men  9 (50%) 45 (54.9%) 
African-American  6 (33.3%) 23 (28.05%) 
Caucasian  11(61.1%) 58 (70.7%) 
Hispanic  0 1 (1.22%) 
Asian  1 (5.6%) 0  
Smoker  4 (22.2%) 18 (22%) 
Non-smoker  13 (72.2%) 51 (62.2%) 
Former smoker  1 (5.6%) 13 (15.9%) 
Diabetes  0 12 (14.6%) 
Hypertension  4 (22.2%) 35 (42.7%) 
Hepatitis  2 (11.1) 2 (2.4%) 
Sickle cell anemia  0 4 (4.9%) 
Epilepsy  1 (5.6%) 2 (2.4%) 
Stroke  0 4 (4.9%) 
Asthma  2 (11.1) 13 (15.9%) 
Tuberculosis  1(5.6%) 3 (3.7%) 
Cancer  1(5.6%) 12 (14.6%) 
Healthy  6 (33.3%) 17 (20.7%) 
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Table 13. Number of teeth lost by age during different follow-up periods 
 
 
 
Figure 1. Number of teeth lost by age and follow-up periods 
 
Age group (years) 1-yr 
 
2-yrs 
 
3-yrs 
 
4-yrs 
 
5-yrs 
 
6-yrs 
 
20-29yrs 4 0 5 3 1 0 
30-39yrs 0 5 0 0 1 2 
40-49yrs 19 2 1 14 8 6 
50-59yrs 20 0 9 26 0 20 
60-69yrs 4 5 0 4 10 2 
70-79yrs 0 4 2 1 7 0 
80-91yrs 0 0 0 2 0 1 
Total number of teeth loss  
 
47 16 17 50 27 31 
1-yr	3-yr	
5-yr	0	5	
10	15	
20	25	
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Table 14. Frequency of tooth loss in relation to age groups 
 
 
 
 
 
 
 
 
 
Table 15. Missing teeth with regards to types of teeth in subjects stratified by age  
 
 
 
 
 
 
 
Age group 
Tooth loss 
TL>0 TL=0 Total  
N  % N  % N  % 
Younger group  9 50 9 50 18 100% 
Older group 50 61 32 39 82 100% 
Total 59 59 41 41 100 100% 
 
 
Type of missing teeth 
Baseline  Final  
Younger   Older  Younger   Older  
Mean Range Total  Mean Range Total  Mean Range Total  Mean Range Total  
Number of Missing teeth  2.28 0-12 73 20.2 2-72 645 2.9 0-13 94 25.4 3-74 812 
Number of Missing anterior teeth 0.08 0-1 1 6.6 2-12 81 0.33 0-1 4 9.4 3-16 113 
Number of Missing premolar teeth 1.6 0-3 13 12.9 3-20 103 1.9 1-3 15 20 9-29 160 
Number of Missing molar teeth 4.9 0-12 59 38.4 19-72 461 6.25 0-13 75 44.9 27-74 539 
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Table 16. Tooth loss difference with regards to types of teeth in subjects stratified by age 
 
 
 
 
 
 
 
 
 
 
 
Types of missing teeth t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
Y
ou
ng
er
 g
ro
up
 (N
=1
8)
 
 
  
       # Missing teeth 
3.13 0.006* -1.95 to -0.38 4.06 2.75 0.65 -1.17 17 0.37 
5.22 2.78 0.65 
 
  #  Missing anterior teeth 
 
1 0.33 -0.52 to 0.18 0.06 0.24 0.06 -0.17 17 0.167 
0.22 0.73 0.17 
 
  #  Missing premolar teeth 
1.46 0.16 -0.27 to 0.05 0.72 1.23 0.29 -0.11 17 0.076 
0.83 1.34 0.32 
 
  #  Missing molar teeth 
2.85 0.011* -1.55 to -0.23 3.28 2.22 0.52 -0.89 17 0.31 
4.17 2.43 0.57 
O
ld
er
 g
ro
up
  (
N
=8
2)
 
 
   #  Missing teeth 
6.37 0.0001* -2.67 to -1.40 7.87 5.04 0.56 -2.04 81 0.32 
9.90 5.61 0.62 
 
  #  Missing anterior teeth 
3.48 0.0008* -0.61 to -0.17 0.99 1.84 0.20 -0.39 81 0.11 
1.38 2.09 0.23 
 
 #  Missing premolar teeth 
5.27 0.0001* -0.96 to -0.43 1.26 1.78 0.20 -0.70 81 0.13 
1.95 2.09 0.23 
 
  #  Missing molar teeth 
5.88 0.0001* -1.27 to -0.63 5.62 2.78 0.31 -0.95 81 0.162 
6.57 2.74 0.30 
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3.5 TOOTH LOSS AND HEALTH STATUS 
By stratifying the study subjects based on their health status, the mean of tooth loss was found to 
be statistically significantly in both healthy individuals and those with systemic diseases  
(healthy group, P=0.0081 and for patients with systemic diseases, P=0.0001) and molars were 
the most significantly lost teeth in both groups (healthy group, P=0.005 and for patients with 
systemic diseases, P=0.0001), (Table 17). 
 
Table 17. Tooth loss difference with regards to types of teeth in subjects stratified by 
health status 
Types of missing teeth t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
H
ea
lth
y 
in
di
vi
du
al
s  
(N
=2
3)
 
 
  
 # Missing teeth 
2.91 0.0081* 3.13 to -0.52 6.17 5.31 1.11 -1.83 22 0.63 
8 5.31 1.11 
 
 #  Missing anterior teeth 
 
1 0.33 -0.53 to 0.19 0.57 1.65 0.34 -0.17 22 0.17 
0.74 1.79 0.37 
 
 #  Missing premolar teeth 
2.37 0.027* -1.14 to-0.08 1.13 1.55 0.32 -0.61 22 0.26 
1.74 1.74 0.36 
 
  #  Missing molar teeth 
 
3.17 0.005* -1.73 to -0.36 4.48 2.92 0.61 -1.04 22 0.33 
5.52 2.81 0.59 
Pa
tie
nt
s w
ith
 sy
st
em
ic
 d
is
ea
se
  (
N
=7
7)
  
#  Missing teeth 
6.28 0.0001* -2.50 to -1.29 7.48 4.81 0.55 -1.90 76 0.30 
9.38 5.57 0.63 
 
#  Missing anterior teeth 
3.52 0.0007* -0.63 to -0.17 0.90 1.73 0.20 -0.40 76 0.11 
1.30 
 
2.01 0.23 
 
#  Missing premolar teeth 
4.75 0.0001* -0.83 to -0.34 1.17 1.76 0.20 -0.58 76 0.12 
1.75 2.10 0.24 
 
#  Missing molar teeth 
5.71 0.0001* -1.23 to -0.59 5.42 2.78 0.32 -0.91 76 0.16 
6.32 2.83 0.32 
 29 
3.6  CLINICAL ATTACHMENT LOSS LEVEL (CAL) 
Periodontal diagnosis was classified according to the American Academy of Periodontology 
guidelines (Armitage, 1999). The severity of periodontal disease is based on the amount of 
clinical attachment loss (CAL) and is designated as mild (1–2 mm CAL), moderate (3–4 mm 
CAL), and severe (>5 mm CAL). Periodontitis is classified as localized if the affected sites are 
30% or less and generalized if there are more than 30% affected sites. The clinical attachment 
level of all six points (the mesial, the mid, and the distal points of both labial/buccal and 
lingual/palatal surfaces) of each standing tooth was recorded for every periodontal evaluation the 
patients underwent. 
3.7 PERIODONTAL HEALTH STATUS OF THE STUDY POPULATION 
Of the 14,527 recorded measurements (missing sites were excluded), 196 (1.35%) sites were 
classified as healthy sites, having no active periodontitis, yet 6,979 (48.04%), 5,762 (39.7%), and 
1,590 sites (10.9%) that were included in the study defined as mild, moderate, and severe CAL 
sites, respectively. The majority of sites with moderate and severe CAL were located on the 
labial/buccal aspects, whereas the lingual/palatal surfaces comprised mainly of sites with mild 
CAL (Tables 18, Figures 2 and 3).  Based on the changes in clinical attachment loss, the patients 
were sorted into three groups: progressive, regressive, and stable. The progressive group 
included the patients who showed an increase in CAL (mean difference of -0.62 mm), whereas 
the regressive group included the patients who showed a reduction in CAL (mean difference of 
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0.62 mm). The stable group of patients displayed approximately CAL difference of 0.097 mm 
(Table 19). 
Table 18. Distribution of sites in the total sample size 
 
Table 19. CAL difference across different groups 
 
Baseline CAL (mm) Sum of labial/buccal sites Sum of lingual/palatal sites  Sum of full mouth sites 
Healthy (0 mm) 102 (0.70%) 94 (0.65%) 196 (1.35%) 
Mild (1-2mm) 3,248 (22.4%) 3731 (25.7%) 6979 (48%) 
Moderate (3-4 mm) 3035 (20.9%) 2727 (18.8%) 5762 (39.7%) 
Severe (≥5mm) 876 (6.03%) 714 (4.9%) 1590 (10.9%) 
Final CAL (mm) Sum of labial/buccal sites Sum of lingual/palatal sites  Sum of full mouth sites 
Healthy (0 mm) 42 (0.29 %) 39 (0.27%) 81 (0.56%) 
Mild (1-2mm) 3173 (21.8%) 3386 (23.3%) 6559 (45.2 %) 
Moderate (3-4 mm) 2966 (20.4%) 2745 (18.9%) 5711 (39.3%) 
Severe (≥5mm) 655 (4.5%) 538 (3.7%) 1193 (8.2%) 
CAL 
t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
St
ab
le
  
Baseline CAL 1.23 0.227 -0.063 to 0.258 2.88 0.65 0.11 0.097 35 0.079 
Final CAL 2.8 0.72 0.12 
Pr
og
re
ss
iv
e   
Baseline CAL 6.57 0.0001* -0.808 to -0.426 2.72 0.78 0.13 -0.617 34 0.094 
Final CAL 3.33 0.798 0.135 
R
eg
re
ss
iv
e  Baseline CAL 6.62 0.0001* 0.429 to 0.813 3.25 0.96 0.18 0.621 28 0.094 
Final CAL 2.62 0.76 0.14 
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Figure 2. Distribution of sites at the baseline periodontal assessments 
 
 
Figure 3. Distribution of sites at the final periodontal assessments 
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3.8 CHANGE IN THE CLINICAL ATTACHMENT LOSS 
Paired t-test was used to measure the difference between the baseline CAL and the CAL that was 
recorded at the final periodontal evaluation in patients at each follow-up period. The mean 
differences of CAL in patients who attended one year of SPT and those who received SPT for six 
years were found to be significant (0.36 mm CAL gain and 0.38 mm progression in CAL, 
respectively). With regards to teeth aspect, the mean difference in CAL at the labial/buccal sides 
was found to be significant at one and two years of SPT (0.44 mm CAL gain and 0.42 mm CAL 
gain, respectively). The lingual/palatal aspects of teeth showed a significant mean difference of 
CAL in patients who were under 5 years of SPT (0.38 mm CAL gain), (Tables 20,21,and 22).  
 
Table 20. Changes in CAL at different follow-up periods 
 
 
SP
T CAL t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
1-
yr
 
Baseline CAL 2.42 0.025* 0.050 to 0.664 3.35  
 
1.12 0.24 0.36 20 0.147 
Final CAL 3 0.87 0.19 
2-
yr
s 
Baseline CAL 1.98 0.0697 -0.032 to 0.718 3.24 0.73 0.194 0.343 13 0.173 
Final CAL 2.89 0.82 0.22 
3-
yr
s 
Baseline CAL 1.06 0.3024 -0.613 to 0.202 2.72 0.714 0.17 -0.206 17 0.193 
Final CAL 2.92 0.67 0.16 
4-
yr
s 
Baseline CAL -0.15 0.2687 -0.418 to 0.123 2.8 0.79 0.17 -0.148 20 0.130 
Final CAL 2.94 1.03 0.23 
5-
yr
s 
Baseline CAL 0.57 0.584 -0.271 to 0.448 2.66 0.43 0.14 0.089 8 0.156 
Final CAL 2.57 0.59 0.195 
6-
yr
s 
Baseline CAL 2.27 0.0373* -0.728 to -0.025 2.71 0.47 0.12 -0.38 16 0.17 
Final CAL 3.08 0.70 0.17 
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Table 21. Changes in labial/ buccal CAL at different follow-up periods 
 
Table 22. Changes in lingual /palatal CAL at different follow-up periods 
 
 
CAL t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
1-
yr
 
Baseline CAL 3.23 0.0042* 0.155 to 0.721 3.36 1.1 0.24 0.438 20 0.136 
Final CAL 2.92 0.84 0.18 
2-
yr
s 
Baseline CAL 2.062 0.0598* -0.020 to 0.863 3.31 0.83 0.22 0.421 13 0.204 
Final CAL 2.89 0.82 0.23 
3-
yr
s 
Baseline CAL 1.012 0.326 -0.549 to 0.193 2.81 0.72 0.17 -0.178 17 0.176 
Final CAL 2.98 0.74 0.17 
4-
yr
s 
Baseline CAL 1.083 0.292 -0.418 to 0.132 2.88 0.82 0.18 -0.143 20 0.132 
Final CAL 3.02 1.09 0.24 
5-
yr
s 
Baseline CAL 0.930 0.3796 -0.197 to 0.464 2.71 0.35 0.12 0.133 8 0.143 
Final CAL 2.58 0.45 0.15 
6-
yr
s 
Baseline CAL 1.859 0.0816 -0.793 to 0.052 2.82 0.53 0.13 -0.371 16 0.199 
Final CAL 3.19 0.78 0.189 
CAL t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
1-
yr
 
Baseline CAL 0.286 0.78 -0.473 to 
0.359 
2.95 0.22 0.048 -0.057 20 0.2 
Final CAL 3 0.94 0.21 
2-
yr
s 
Baseline CAL 0.587 0.57 -0.325 to 
0.568 
3 0.0 0.0 0.121 13 0.207 
Final CAL 2.9 0.77 0.21 
3-
yr
s 
Baseline CAL 1.026 0.319 -0.170 to 
0.492 
2.94 0.24 0.056 0.161 17 0.157 
Final CAL 2.78 0.693 0.163 
4-
yr
s 
Baseline CAL 0.588 0.563 -0.352 to 
0.628 
3 0.0 0.0 0.138 20 0.24 
Final CAL 2.86 1.07 0.24 
5-
yr
s 
Baseline CAL 2.204 0.0586* -0.018 to 
0.773 
3 0.0 0.0 0.378 8 0.17 
Final CAL 2.6 0.51 0.17 
6-
yr
s 
Baseline CAL 0.454 0.656 -0.467 to 
0.303 
2.94 0.24 0.059 -0.082 16 0.182 
Final CAL 3.02 0.79 0.19 
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3.9  CLINICAL ATTACHMENT LOSS AND AGE 
We have measured the difference in number of sites with different periodontal status at the 
labial/buccal and lingual /palatal aspects of teeth in both age groups, regardless of the length of 
supportive periodontal therapy. We found that the mean difference in number of sites with stable, 
mild, moderate and severe CAL on both labial/buccal and lingual/palatal aspects were non-
significant in younger patients (Table 23).  
 
In older group, patients showed a statistically significant reduction in number of sites with stable 
and severe CAL on the labial/buccal aspects (mean difference of 0.41 and 1.99, respectively). 
Also, the lingual/palatal aspect of teeth in older patients exhibited a significant reduction in 
number of sites with stable and severe CAL with mean difference of 0.46 and 1.83 sites, 
respectively (Table 24). 
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Table 23. CAL difference with regards to teeth aspects in younger group 
Table 24. CAL difference with regards to teeth aspects in older group 
Clinical attachment loss t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
   
La
bi
al
/ B
uc
ca
l a
sp
ec
t  
(N
=1
8)
 
 
Stable CAL 1.23 0.235 -1.03 to 3.92 3.28 9 2.12 1.44 17 1.17 
1.83 5.9 1.39 
Mild CAL 
 
0.049 0.961 -7.29 to 6.96 45.2 17.24 4.06 -0.17 17 3.38 
45.3 16.72 3.94 
Moderate CAL 1.34 0.198 -11.88 to 2.65 25.33 12.34 2.91 -4.61 17 3.44 
29.94 18.10 4.27 
Severe CAL 1.358 0.192 -1.66 to 7.66 5.39 9.49 2.24 3 17 2.21 
2.39 2.77 0.65 
Li
ng
ua
l/P
al
at
al
 a
sp
ec
t  
(N
=1
8)
 Stable CAL 0.911 0.375 -1.24 to 3.13 2.89 5.89 1.39 0.94 17 1.037 
1.94 6.61 1.56 
Mild CAL 
 
1.468 0.161 -2.19 to 12.19 50.22 18.43    4.34 5 17 3.407 
45.22 16.25 3.83 
Moderate CAL 0.626 0.54 -11.65 to 6.32 23.89 14.29 3.37 -2.67 17 4.26 
26.56 14.44 3.40 
Severe CAL 1.434 0.1698 -0.81 to 4.26 2.89 4.98 1.17 1.72 17 1.201 
1.17 1.86 0.44 
Clinical attachment loss t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
   
La
bi
al
/ B
uc
ca
l a
sp
ec
t (
N
=8
2)
 
  
     Stable CAL 2.20 0.031* 0.04 to 0.79 0.52 1.53 0.17 0.41 81 0.19 
0.11 0.69 0.08 
Mild CAL 
 
0.46 0.65 -3.15 to 5.05 29.7 15.24 1.68 0.95 81 2.06 
28.7 16.79 1.85 
Moderate CAL 1.04 0.299 -1.68 to 5.38 31.45 13.41 1.48 1.85 81 1.78 
29.60 14.63 1.62 
   Severe CAL 2.14 0.035* 0.14 to 3.83 9.44 9.65 1.07 1.99 81 0.93 
7.45 8.50 0.94 
Li
ng
ua
l/P
al
at
al
 a
sp
ec
t  
(N
=8
2)
 
 
     Stable CAL 2.10 0.039* 0.03 to 0.90 0.51 1.95 0.22 0.46 81 0.22 
0.05 0.35 0.04 
Mild CAL 
 
1.55 0.124 -0.87 to 7.09 34.48 17.90 1.98 3.11 81 2 
31.37 17.15 1.89 
Moderate CAL 0.211 0.834 -3.09 to 3.82 28.01 12.72 1.40 0.37 81 1.74 
27.65 14.51 1.60 
   Severe CAL 1.98 0.051* -0.01 to 3.67 8.04 9.83 1.09 1.83 81 0.92 
6.21 7.46 0.82 
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3.10 CLINICAL ATTACHMENT LOSS AND HEALTH STATUS 
In the group of healthy individuals, the number of sites with mild CAL reduced significantly as a 
result of SPT with mean difference of 11.7 sites on the lingual/palatal aspects. Whereas, sites 
with moderate CAL were increased (mean difference of 7.13 sites) on the lingual/palatal aspects 
(Table 25).  
 
Patients with systemic disease showed a significant reduction in number of sites with stable and 
severe CAL on the labial/buccal aspects (mean difference of 0.53 and 2.91 sites, respectively). 
On the lingual/palatal aspects, only the number of sites with severe CAL was reduced 
significantly with mean difference of 2.42 sites (Table 26). 
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Table 25. CAL difference with regards to teeth aspects in healthy individuals 
Table 26. CAL difference with regards to the teeth aspects in patients with systemic diseases 
Clinical attachment 
loss 
t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
 L
ab
ia
l/ 
B
uc
ca
l a
sp
ec
t (
N
=2
3)
 
 
Stable CAL 1.006 0.325 -0.88 to 2.53 1.17 3.75 0.78 0.83 22 0.821 
0.35 1.03 0.21 
Mild CAL 
 
1.45 0.16 -2.58 to 14.58 36.70 16.13 3.36 6 22 4.14 
30.70 16.64 3.47 
Moderate CAL 0.17 0.867 -7.46 to 6.33 32.04 14.76 3.08 -0.57 22 3.324 
32.61 15.13 3.16 
Severe CAL 0.18 0.860 -3.85 to 3.24 7.35 7.43 1.55 -0.30 22 1.710 
7.65 7.81 1.63 
Li
ng
ua
l/P
al
at
al
 a
sp
ec
t (
N
=2
3)
 Stable CAL 1.42 0.17 -0.44 to2.36 1.26 3.88 0.81 0.96 22 0.676 
0.30 1.06 0.22 
Mild CAL 
 
3.084 0.0054* 3.83 to 19.56 43.96 16.14 3.37 11.7 22 3.79 
32.26 16.49 3.44 
Moderate CAL 2.32 0.0297* -13.49 to -0.77 25.43 11.79 2.46 -7.13 22 3.07 
32.57 13.16 2.74 
Severe CAL 0.14 0.89 3.43 to 2.99 6.17 9.41 1.96 -0.22 22 1.55 
6.39 8.25 1.72 
Clinical attachment loss t P-value 95%CI Mean SD SEM Mean diff df SE of diff 
 L
ab
ia
l/ 
B
uc
ca
l a
sp
ec
t (
N
=7
7)
 
 
     Stable CAL 2.25 0.028* 0.06 to 1.00 0.97 4.24 0.48 0.53 76 0.24 
0.44 2.92 .33 
Mild CAL 
 
0.42 0.68 -4.70 to3.06 31.22 16.67 1.90 -0.82 76 1.95 
32.04 18.33 2.09 
Moderate CAL 0.583 0.562 -2.57 to4.70 29.84 13 1.48 1.06 76 1.83 
28.78 15.22 1.73 
   Severe CAL 2.98 0.0038* 0.97 to 4.85 9.12 10.29 1.17 2.91 76 0.98 
6.21 8.10 0.92 
Li
ng
ua
l/P
al
at
al
 a
sp
ec
t (
N
=7
7)
 
     Stable CAL 1.60 0.113 -0.10 to0.96 0.84 2.92 0.33 0.43 76 0.27 
0.42 3.21 0.37 
Mild CAL 
 
0.522 0.602 -2.77 to4.75 35.32 19.31 2.20 0.99 76 1.89 
34.34 18.16 2.07 
Moderate CAL 1.04 0.302 -1.74 to5.53 27.82 13.41 1.53 1.90 76 1.83 
25.92 14.52 1.65 
   Severe CAL 2.67 0.0091* 0.62 to 4.21 7.39 9.37 1.07 2.42 76 0.903 
4.97 6.70 0.76 
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4.0  DISCUSSION 
 Our study evaluated the impact of supportive periodontal care program in patients diagnosed 
with moderate to severe chronic periodontitis. These patients had been maintained in supportive 
periodontal therapy (SPT) for a period that ranged between one to six years. We have used both 
tooth loss and the changes in clinical attachment loss to evaluate the patients’ responses to 
periodontal treatment.  
 
                 Tooth loss has been considered a true clinical end point and it has been widely used as 
a clinical parameter to evaluate the efficacy of dental treatment (Hujoel, 2004). Clinical 
attachment loss is also a useful clinical measure that indicates the presence of periodontitis, but 
not necessarily the activity of the disease.  
 
               This research attempted to determine the gain and the progression in CAL with respect 
to different length of supportive periodontal care. An attempt was also made to find if changes in 
CAL differ with respect to teeth aspects that may be influenced by the accessibility for oral-self 
care. Additionally, the changes in the number of sites with different degree of CAL were studied 
in patients stratified by age and health condition. 
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                 In our study sample, sex was not found to be significantly associated with tooth loss 
(P= 0.11). Sexual disparities in tooth loss could be associated with risk factors such as smoking. 
It was reported that smoking increased the risk of tooth loss in men to 2.4-folds, whereas in 
women the risk of tooth loss can reach up to 3.5-folds (Krall et al., 1997). It was suggested that 
testosterone levels can serve as a predictor for tooth loss in men. The testosterone levels in men 
who aged 30-65 years with tooth loss of >3 or >5 were significantly lower than in those without 
tooth loss (Singh et al., 2011).  
 
                  The results of this retrospective study revealed that a statistically significant 
relationship existed between diabetes and tooth loss as well as hypertension and tooth loss. These 
findings are consistent with previous studies (Kaur et al., 2009; Peres et al., 2012). It was 
previously reported that African Americans were at greater risk of tooth loss (Drake et al., 1995; 
Gilbert and Shelton, 2003). In our study tooth loss was not found to be associated with ethnicity. 
However, Caucasians tended to lose more teeth during SPT in our sample.  
 
                    Younger individuals showed statistically significant increase in the number of 
missing teeth (P=0.006). Expectedly, younger patients failed to report significant changes in 
number of sites with regards to the severity of CAL on both labial/buccal and lingual/palatal 
aspects. These findings can be attributed to small sample size and limited number of patients in 
the younger group (Table 23).  
 
 
 40 
                At baseline, older patients reported several health issues such as diabetes and 
hypertension that may contribute in periodontitis progression. Many studies have investigated the 
association between periodontal disease, tooth loss, and several systemic diseases, including 
diabetes mellitus, cancer, and cardiovascular disease (Axelsson and Lindhe, 1981). 
 
               In older group, a significant reduction in number of sites with periodontally stable CAL 
was detected on both labial/buccal and lingual/palatal aspects (P=0.031 and P=0.039, 
respectively). These findings indicated the progression of periodontal disease in older patients. 
Also, the number of sites with severe CAL was significantly reduced on both labial/buccal and 
lingual/palatal aspects (P=0.035 and 0.051, respectively). Greater reduction in number of sites 
with severe CAL is possibly a surrogate for the significant increase in tooth loss that was seen in 
older patients (P=0.0001). 
  
               Based on our analysis, there was no significant difference between healthy individuals 
and patients with systemic disease in terms of tooth loss (P=1). However, both groups showed a 
statistically significant difference in the number of missing teeth (healthy subjects, P=0.0081 and 
patients with systemic disease, P=0.0001).  
 
             Within the healthy group of patients, we found a significant reduction in the number of 
sites with mild CAL on lingual/palatal aspects (P=0.0054). Moreover, a significant increase in 
the number of sites with moderate CAL was detected on the lingual/palatal aspects (P=0.0297). 
These findings may be affected by the greater number of healthy individuals existed in older 
group (n=17).   
 41 
 
 
              In the group of patients with systemic disease, the number of sites with stable CAL on 
labial/buccal was significantly reduced (P=0.028). The number of sites with severe CAL on both 
labial/buccal and lingual/palatal aspects was also found to be significantly reduced (P=0.0038 
and P=0.0091, respectively) these findings resulted in the effect of systemic disease on tooth loss 
and periodontal disease progression. 
 
               The changes in CAL was found to be significant in the group of patients who had been 
under supportive periodontal therapy for one year (CAL gain= 0.36 mm) Also, a slight 
progression in CAL of 0.38 mm was found to be statistically significant in patients in their the 6th 
year of supportive periodontal therapy. This change can be the result of underlying systemic 
disease that can modify the rate of periodontitis progression. 
 
             The assessment of risk level for periodontal disease progression in patients is necessary 
to determine the frequency of SPT visits and the extent of professional support necessary for 
each patient (Brägger et al., 1992). It has been suggested that patients with advanced 
periodontitis may need SPT with visits at shorter time interval (3-4 months). While for mild-to-
moderate forms of periodontitis, one annual visit may be enough to prevent further clinical 
attachment loss (Lang and Lindhe, 2015). 
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              In order to make a precise measurement of incidence of tooth loss, all teeth that had 
been lost, including those that were extracted during the active phase of treatment, were included 
in this study. We found that tooth mortality rate was higher in the group under one year SPT 
compared to those who maintained SPT for six years. 
 
              With regards to teeth aspect, the mean difference in CAL at the buccal/labial side was 
found to be significant at one and two years of SPT (0.44 mm CAL gain and 0.42 mm CAL gain, 
respectively). The lingual/palatal aspect of teeth showed a significant gain in CAL of 0.38 mm 
among the patients who had attended SPT for 5 years. 
 
              In our study we did not find and association between tooth loss and interleukin-1 
polymorphisms. Similar findings were reported in previous studies (Cattabriga et al., 2001; 
Huynh‐Ba et al., 2007). According to a recent review on gene polymorphisms associated with 
chronic periodontitis, several studies have failed to show significant association between IL-1 
and the susceptibility to chronic periodontitis (Laine et al., 2010).  
 
        Numerous genetic polymorphisms have been identified and tested as prognostic or 
diagnostic markers for the susceptibility to periodontal disease progression including vitamin D 
receptor, transforming growth factor-β, interleukin 6 and 10, and interferon-γ gene 
polymorphisms (Tachi et al., 2003; Babel et al., 2006 ; Wu et al., 2015).  
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5.0  CONCLUSION 
The purpose of this study was to compare the use of clinical attachment loss and tooth loss in 
evaluating the pattern of periodontal disease progression with regards to the patients related 
factors such as; age, IL-1 polymorphisms and health condition.  
 
                Our results showed that tooth loss was associated with diabetes and hypertension. 
However, no significant association was noted between tooth loss and IL-1 polymorphisms. 
Although the gain in CAL appeared to be clinically non-significant, supportive periodontal 
therapy was found to be effective in arresting the progression of periodontal disease in high-risk 
patients.  
 
   Based on our data, we can conclude that: 
1. Subjects in the sample had moderate to severe periodontitis. 
2. Patients with periodontitis often have concomitant diabetes or hypertension. 
3. Reduction in both tooth loss and clinical attachment loss after periodontal treatment, 
suggested that periodontal treatments offered to patients in the sample is satisfactory. 
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